Symbols / CNTX Stock $2.26 -2.59% Context Therapeutics Inc.

Healthcare • Biotechnology • United States • NCM
CNTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Martin A. Lehr
Exch · Country NCM · United States
Market Cap 207.65M
Enterprise Value 141.76M
Income -36.12M
Sales —
FCF (ttm) -19.13M
Book/sh 0.66
Cash/sh 0.72
Employees 15
Insider 10d —
IPO Oct 20, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -4.89
PEG —
P/S —
P/B 3.43
P/C —
EV/EBITDA -3.57
EV/Sales —
Quick Ratio 8.23
Current Ratio 8.52
Debt/Eq 0.18
LT Debt/Eq —
EPS (ttm) -0.38
EPS next Y -0.46
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-23
Earnings (prior) 2026-03-23
ROA -29.79%
ROE -46.39%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 91.88M
Shs Float 42.72M
Insider Own 1.18%
Instit Own 76.80%
Short Float 1.14%
Short Ratio 1.14
Short Interest 863.74K
52W High 3.62
vs 52W High -37.57%
52W Low 0.49
vs 52W Low 361.22%
Beta 1.83
Impl. Vol. —
Rel Volume 2.10
Avg Volume 1.19M
Volume 2.51M
Target (mean) $6.00
Tgt Median $5.50
Tgt Low $4.00
Tgt High $9.00
# Analysts 8
Recom Strong_buy
Prev Close $2.32
Price $2.26
Change -2.59%
About

Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$2.26
Latest analyst target
3. DCF / Fair value
$-3.75
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.26
Low
$4.00
High
$9.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-24 main D. Boral Capital Buy → Buy $9
2026-03-24 reit Guggenheim Buy → Buy $5
2026-03-24 main Piper Sandler Overweight → Overweight $7
2025-12-22 init Jones Trading — → Buy $7
2025-11-06 main D. Boral Capital Buy → Buy $9
2025-11-06 main HC Wainwright & Co. Buy → Buy $5
2025-10-16 main D. Boral Capital Buy → Buy $9
2025-10-02 init Cantor Fitzgerald — → Overweight —
2025-09-18 init Guggenheim — → Buy $5
2025-08-07 main D. Boral Capital Buy → Buy $9
2025-08-07 main HC Wainwright & Co. Buy → Buy $4
2025-06-26 reit Piper Sandler Overweight → Overweight $4
2025-05-08 main D. Boral Capital Buy → Buy $9
2025-04-29 main D. Boral Capital Buy → Buy $9
2025-04-21 init William Blair — → Outperform —
2025-04-09 main D. Boral Capital Buy → Buy $9
2025-03-21 reit HC Wainwright & Co. Buy → Buy $5
2025-03-21 main D. Boral Capital Buy → Buy $9
2025-01-15 main D. Boral Capital Buy → Buy $9
2025-01-08 init JMP Securities — → Market Outperform $4
News
RSS: Latest CNTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-06-09 LEHR MARTIN A Chief Executive Officer — 100,000 $0.70 $70,080
2025-06-06 MINAI-AZARY JENNIFER LYNN Chief Financial Officer — 40,010 $0.64 $25,486
2025-06-06 LEVIT ALEX C. Officer — 20,000 $0.58 $11,520
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
39.70
+32.68%
29.92
+19.35%
25.07
+68.49%
14.88
Research And Development
31.86
+40.33%
22.70
+27.66%
17.78
+150.77%
7.09
Selling General And Administration
7.85
+8.64%
7.22
-0.92%
7.29
-6.42%
7.79
General And Administrative Expense
7.85
+8.64%
7.22
-0.92%
7.29
-6.42%
7.79
Other Gand A
7.85
+8.64%
7.22
-0.92%
7.29
-6.42%
7.79
Total Expenses
39.70
+32.68%
29.92
+19.35%
25.07
+68.49%
14.88
Operating Income
-39.70
-32.68%
-29.92
-19.35%
-25.07
-68.49%
-14.88
Total Operating Income As Reported
-39.70
-32.68%
-29.92
-19.35%
-25.07
-63.01%
-15.38
EBITDA
-39.69
-32.67%
-29.91
-19.36%
-25.06
-68.51%
-14.87
Normalized EBITDA
-39.69
-32.67%
-29.91
-19.36%
-25.06
-74.37%
-14.37
Reconciled Depreciation
0.02
+49.35%
0.01
-9.66%
0.01
+29.95%
0.01
EBIT
-39.70
-32.68%
-29.92
-19.35%
-25.07
-68.49%
-14.88
Total Unusual Items
—
—
0.00
+100.00%
-0.50
Total Unusual Items Excluding Goodwill
—
—
0.00
+100.00%
-0.50
Special Income Charges
—
—
0.00
+100.00%
-0.50
Other Special Charges
—
—
—
0.50
Restructuring And Mergern Acquisition
—
—
—
—
Net Income
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Pretax Income
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Net Non Operating Interest Income Expense
3.38
+5.57%
3.20
+174.94%
1.16
+112.69%
0.55
Interest Expense Non Operating
—
—
—
—
Net Interest Income
3.38
+5.57%
3.20
+174.94%
1.16
+112.69%
0.55
Interest Expense
—
—
—
—
Interest Income Non Operating
3.38
+5.57%
3.20
+174.94%
1.16
+112.69%
0.55
Interest Income
3.38
+5.57%
3.20
+174.94%
1.16
+112.69%
0.55
Other Income Expense
0.20
+14138.59%
-0.00
+97.43%
-0.06
+88.93%
-0.50
Other Non Operating Income Expenses
0.20
+14138.59%
-0.00
+97.43%
-0.06
-2672.95%
-0.00
Gain On Sale Of Security
—
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Net Income From Continuing Operation Net Minority Interest
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Net Income From Continuing And Discontinued Operation
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Net Income Continuous Operations
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Normalized Income
-36.12
-35.17%
-26.73
-11.52%
-23.96
-67.16%
-14.34
Net Income Common Stockholders
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Diluted EPS
-0.38
+17.39%
-0.46
+69.33%
-1.50
-61.29%
-0.93
Basic EPS
-0.38
+17.39%
-0.46
+69.33%
-1.50
-61.29%
-0.93
Basic Average Shares
95.19
+62.94%
58.42
+265.88%
15.97
+0.00%
15.97
Diluted Average Shares
95.19
+62.94%
58.42
+265.88%
15.97
+0.00%
15.97
Diluted NI Availto Com Stockholders
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Line Item Trend 2023-12-31
Total Assets
16.06
Current Assets
16.05
Cash Cash Equivalents And Short Term Investments
14.45
Cash And Cash Equivalents
14.45
Prepaid Assets
—
Other Current Assets
1.60
Total Non Current Assets
0.02
Net PPE
0.02
Gross PPE
0.02
Other Properties
0.02
Non Current Deferred Assets
—
Other Non Current Assets
—
Total Liabilities Net Minority Interest
4.19
Current Liabilities
4.19
Payables And Accrued Expenses
3.53
Payables
2.38
Accounts Payable
2.38
Current Accrued Expenses
1.15
Pensionand Other Post Retirement Benefit Plans Current
0.65
Current Debt And Capital Lease Obligation
—
Current Capital Lease Obligation
0.00
Other Current Liabilities
0.01
Total Non Current Liabilities Net Minority Interest
0.00
Long Term Debt And Capital Lease Obligation
0.00
Long Term Capital Lease Obligation
0.00
Preferred Securities Outside Stock Equity
—
Stockholders Equity
11.87
Common Stock Equity
11.87
Capital Stock
0.02
Common Stock
0.02
Preferred Stock
0.00
Share Issued
15.97
Ordinary Shares Number
15.97
Treasury Shares Number
0.00
Additional Paid In Capital
79.91
Retained Earnings
-68.05
Total Equity Gross Minority Interest
11.87
Total Capitalization
11.87
Working Capital
11.86
Invested Capital
11.87
Total Debt
0.00
Capital Lease Obligations
0.00
Net Tangible Assets
11.87
Tangible Book Value
11.87
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-26.39
-81.26%
-14.56
+30.84%
-21.05
-55.34%
-13.55
Cash Flow From Continuing Operating Activities
-26.39
-81.26%
-14.56
+30.84%
-21.05
-55.34%
-13.55
Net Income From Continuing Operations
-36.12
-35.17%
-26.73
-11.52%
-23.96
-61.53%
-14.84
Depreciation Amortization Depletion
0.02
+49.35%
0.01
-9.66%
0.01
+29.95%
0.01
Depreciation And Amortization
0.02
+49.35%
0.01
-9.66%
0.01
+29.95%
0.01
Other Non Cash Items
2.00
-86.44%
14.75
—
0.50
Stock Based Compensation
1.33
+58.11%
0.84
-21.82%
1.08
+10.28%
0.98
Operating Gains Losses
0.11
+159.21%
0.04
-19.52%
0.05
-33.82%
0.08
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
0.11
+159.21%
0.04
-19.52%
0.05
-33.82%
0.08
Change In Working Capital
6.28
+280.74%
-3.48
-295.75%
1.78
+739.84%
-0.28
Change In Prepaid Assets
1.11
+159.27%
-1.87
-346.27%
0.76
+203.09%
-0.74
Change In Payables And Accrued Expense
5.28
+437.33%
-1.57
-250.68%
1.04
+83.39%
0.57
Change In Accrued Expense
4.19
+775.44%
-0.62
-52.10%
-0.41
-130.08%
1.35
Change In Payable
1.10
+215.84%
-0.95
-165.40%
1.45
+283.61%
-0.79
Change In Account Payable
1.10
+215.84%
-0.95
-165.40%
1.45
+283.61%
-0.79
Change In Other Current Assets
—
0.00
-100.00%
0.03
+200.00%
-0.03
Change In Other Current Liabilities
-0.11
-160.11%
-0.04
+25.09%
-0.06
+26.96%
-0.08
Investing Cash Flow
-2.03
+86.22%
-14.76
0.00
+100.00%
-0.54
Cash Flow From Continuing Investing Activities
-2.03
+86.22%
-14.76
0.00
+100.00%
-0.54
Net PPE Purchase And Sale
-0.03
-364.02%
-0.01
0.00
+100.00%
-0.04
Purchase Of PPE
-0.03
-364.02%
-0.01
0.00
+100.00%
-0.04
Capital Expenditure
-2.03
+86.22%
-14.76
—
-0.54
Net Intangibles Purchase And Sale
-2.00
+86.44%
-14.75
0.00
+100.00%
-0.50
Purchase Of Intangibles
-2.00
+86.44%
-14.75
0.00
+100.00%
-0.50
Financing Cash Flow
-0.02
-100.01%
109.29
0.00
+100.00%
-0.10
Cash Flow From Continuing Financing Activities
-0.02
-100.01%
109.29
0.00
+100.00%
-0.10
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
0.00
-100.00%
109.29
0.00
0.00
Net Other Financing Charges
-0.02
—
—
-0.10
Changes In Cash
-28.43
-135.55%
79.98
+480.00%
-21.05
-48.35%
-14.19
Beginning Cash Position
94.43
+553.50%
14.45
-59.29%
35.50
-28.56%
49.69
End Cash Position
66.00
-30.11%
94.43
+553.50%
14.45
-59.29%
35.50
Free Cash Flow
-28.42
+3.05%
-29.31
-39.27%
-21.05
-49.42%
-14.09
Common Stock Issuance
0.00
-100.00%
109.29
0.00
0.00
Issuance Of Capital Stock
0.00
-100.00%
109.29
0.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category